Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.14
Delayed Data
As of 12:34pm ET
 +0.01 / +0.88%
Today’s Change
1.04
Today|||52-Week Range
1.85
-20.28%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close1.13
Today’s open1.14
Day’s range1.13 - 1.14
Volume180,899
Average volume (3 months)298,690
Market cap$108.6M
Dividend yield--
Data as of 12:34pm ET, 02/28/2017

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+651.19%
P/E ratioNM
Price/Sales37.16
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...-0.02-1.85%
ADVMAdverum Biotechnolog...-0.02-0.91%
CFRXContraFect Corp-0.10-4.44%
BPTHBio Path Holdings In...-0.00-0.14%
Data as of 12:59pm ET, 02/28/2017

Financials

Last reporting dateFebruary 28, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$2.8M
Annual profit (last year)-$23.2M
Net profit margin-816.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Zami Aberman
President, COO, CFO, Secretary &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts


Search for Jobs